Abstract
Neuroimaging methods can play an increasingly important role in a highly complex drug development process by providing sensitive biomarkers of disease state and the effects of therapeutic intervention. Based on the functional mapping of the anatomical specificity of drug effects, neuroimaging methods can illuminate the basic mechanisms of a disease and can assist in guiding the development of drugs with high specificity and sensitivity in the context of clinical applications and the increased reliance on personalized medicine. Magnetoencephalography (MEG) reflects synaptic currents directly, it is free of vascular confounds, and its sources can be modeled with increasingly sophisticated algorithms that often incorporate complementary imaging modalities, making it highly applicable to neuropsychopharmacological investigations. Indeed, numerous MEG studies have examined spontaneous or task-related brain activity in response to neuromodulators and drugs of abuse. With emphasis on the spectral analysis models, this chapter briefly reviews the MEG studies manipulating GABA, acetylcholine, dopamine, glutamate and alcohol in healthy cohorts, as well as the research on Parkinson’s disease, attention deficit hyperactivity disorder, and anesthesia in epilepsy. These studies provide unique insight into the spatiotemporal characteristics of the effects of pharmacological agents on different neurofunctional systems in health and disease and can reveal their effects on the oscillatory synchrony in real time and at the level of an interactive multifocal system. The MEG is increasingly relevant for understanding the neuropharmacology of psychoactive substances and for developing realistic neural models of the neuropsychiatric disorders and their sensitivity to pharmacological intervention.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahveninen J, Lin FH, Kivisaari R, Autti T, Hämäläinen M, Stufflebeam S, Belliveau JW, Kahkonen S (2007) MRI-constrained spectral imaging of benzodiazepine modulation of spontaneous neuromagnetic activity in human cortex. Neuroimage 35(2):577–582
Ametamey SM, Honer M (2007) Pharmacological prerequisites for PET ligands and practical issues in preclinical PET research. PET Chemistry 62:317–327
Atkinson AJ Jr, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95
Bagic A, Funke ME, Ebersole J (2009) American Clinical MEG Society (ACMEGS) position statement: the value of magnetoencephalography (MEG)/magnetic source imaging (MSI) in noninvasive presurgical evaluation of patients with medically intractable localization-related epilepsy. J Clin Neurophysiol 26(4):290–293
Baker SN (2007) Oscillatory interactions between sensorimotor cortex and the periphery. Curr Opin Neurobiol 17(6):649–655
Balakrishnan G, Grover KM, Mason K, Smith B, Barkley GL, Tepley N, Bowyer SM (2007) A retrospective analysis of the effect of general anesthetics on the successful detection of interictal epileptiform activity in magnetoencephalography. Anesth Analg 104(6):1493–1497
Barkley GL (2004) Controversies in neurophysiology. MEG is superior to EEG in localization of interictal epileptiform activity: Pro. Clin Neurophysiol 115(5):1001–1009
Barry RJ, Clarke AR, Johnstone SJ (2003) A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin Neurophysiol 114(2):171–183
Bass JK, Bornemann TH, Burkey M, Chehil S, Chen L, Copeland JR, Eaton WW, Ganju V, Hayward E, Hock RS, Kidwai R, Kolappa K, Lee PT, Minas H, Or F, Raviola GJ, Saraceno B, Patel V (2012) A united nations general assembly special session for mental, neurological, and substance use disorders: the time has come. PLoS Med 9(1):e1001159
Bauer M, Kluge C, Bach D, Bradbury D, Heinze HJ, Dolan RJ, Driver J (2012) Cholinergic enhancement of visual attention and neural oscillations in the human brain. Curr Biol 22(5):397–402
Baumgartner C (2004) Controversies in clinical neurophysiology. MEG is superior to EEG in the localization of interictal epileptiform activity: Con. Clin Neurophysiol 115(5):1010–1020
Baumgartner C, Pataraia E (2006) Revisiting the role of magnetoencephalography in epilepsy. Curr Opin Neurol 19(2):181–186
Berg D (2008) Biomarkers for the early detection of Parkinson’s and Alzheimer’s disease. Neurodegenerative Dis 5(3–4):133–136
Bergman H, Deuschl G (2002) Pathophysiology of Parkinson’s disease: from clinical neurology to basic neuroscience and back. Mov Disord 17(Suppl 3):S28–S40
Bitter I, Angyalosi A, Czobor P (2012) Pharmacological treatment of adult ADHD. Curr Opin Psychiatry 25(6):529–534
Boeijinga PH, Soufflet L, Santoro F, Luthringer R (2007) Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: An attempt for modelling some symptoms of psychosis in man. J Psychopharmacol 21(3):321–337
Bohnen NI, Albin RL (2011) The cholinergic system and Parkinson disease. Behav Brain Res 221(2):564–573
Borsook D, Beccera LR, Bullmore ET, Hargreaves RJ (eds) (2009) Imaging in CNS drug discovery and development: implications for disease and therapy. Springer, New York
Borsook D, Hargreaves R, Becerra L (2011) Can functional magnetic resonance imaging improve success rates in CNS drug discovery? Expert Opin Drug Discov 6(6):597–617
Bosboom JL, Stoffers D, Stam CJ, Berendse HW, Wolters E (2009a) Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson’s disease related dementia. Clin Neurophysiol 120(5):910–915
Bosboom JL, Stoffers D, Stam CJ, van Dijk BW, Verbunt J, Berendse HW, Wolters E (2006) Resting state oscillatory brain dynamics in Parkinson’s disease: an MEG study. Clin Neurophysiol 117(11):2521–2531
Bosboom JL, Stoffers D, Wolters E (2003) The role of acetylcholine and dopamine in dementia and psychosis in Parkinson’s disease. J Neural Transm Suppl 65:185–195
Bosboom JL, Stoffers D, Wolters E, Stam CJ, Berendse HW (2009b) MEG resting state functional connectivity in Parkinson’s disease related dementia. J Neural Transm 116(2):193–202
Botvinick MM (2007) Conflict monitoring and decision making: Reconciling two perspectives on anterior cingulate function. Cogn Affect Behav Neurosci 7(4):356–366
Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD (2011) Economic costs of excessive alcohol consumption in the U.S., 2006. Am J Prev Med 41(5):516–524
Brooks DJ (2007) Imaging non-dopaminergic function in Parkinson’s disease. Mol Imag Biol 9(4):217–222
Brown P, Mazzone P, Oliviero A, Altibrandi MG, Pilato F, Tonali PA, Di Lazzaro V (2004) Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson’s disease. Exp Neurol 188(2):480–490
Brunelin J, Fecteau S, Suaud-Chagny MF (2013) Abnormal striatal dopamine transmission in schizophrenia. Curr Med Chem 20(3):397–404
Buxton RB (2002) Introduction to functional magnetic resonance imaging. Cambridge University Press, New York
Buzsaki G (2006) Rhythms of the brain. Oxford University Press, New York
Cadenhead KS (2002) Vulnerability markers in the schizophrenia spectrum: Implications for phenomenology, genetics, and the identification of the schizophrenia prodrome. Psychiatr Clin North Am 25(4):837–853
Cappell J, Schevon C, Emerson RG (2006) Magnetoencephalography in epilepsy: tailoring interpretation and making inferences. Curr Neurol Neurosci Rep 6(4):327–331
Carter CS, van Veen V (2007) Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci 7(4):367–379
Caselli RJ, Beach TG, Yaari R, Reiman EM (2006) Alzheimer’s disease a century later. J Clin Psychiatry 67(11):1784–1800
CDCP (2011) Vital signs: alcohol-impaired driving among adults–United States, 2010. Morb Mortal Wkly Rep 60(39):1351–1356
Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75(7):711–721
Cherkasova MV, Hechtman L (2009) Neuroimaging in attention-deficit hyperactivity disorder: Beyond the frontostriatal circuitry. Can J Psychiatry 54(10):651–664
Coelho M, Ferreira JJ (2012) Late-stage Parkinson disease. Nat Rev Neurol 8(8):435–442
Cubillo A, Halari R, Smith A, Taylor E, Rubia K (2012) A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with attention deficit hyperactivity disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 48(2):194–215
Curran C, Byrappa N, McBride A (2004) Stimulant psychosis: systematic review. Br J Psychiatry 185:196–204
Dager SR, Corrigan NM, Richards TL, Posse S (2008) Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging 19(2):81–96
Dalby NO (2000) GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology 39(12):2399–2407
Dale AM, Liu AK, Fischl BR, Buckner RL, Belliveau JW, Lewine JD, Halgren E (2000) Dynamic statistical parametric mapping: Combining fMRI and MEG for high-resolution imaging of cortical activity. Neuron 26(1):55–67
Dieterle F, Marrer E (2008) New technologies around biomarkers and their interplay with drug development. Anal Bioanal Chem 390(1):141–154
Eckart C, Bunzeck N (2012) Dopamine modulates processing speed in the human mesolimbic system. Neuroimage 66C:293–300
Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48:649–684
Field M, Wiers RW, Christiansen P, Fillmore MT, Verster JC (2010) Acute alcohol effects on inhibitory control and implicit cognition: implications for loss of control over drinking. Alcohol Clin Exp Res 34(8):1346–1352
Finn P (2000) Acute effects of alcohol on cognition and impulsive-disinhibited behavior. In: Noronha A, Eckardt M, Warren K (eds) Review of NIAAA’s neuroscience and behavioral research portfolio, vol 34., US Department of Health and Human ServicesBethesda, MD, pp 337–356
Franzen JD, Wilson TW (2012) Amphetamines modulate prefrontal gamma oscillations during attention processing. NeuroReport 23(12):731–735
Fujimoto A, Ochi A, Imai K, Chan D, Sharma R, Viljoen A, Chu B, Holowka S, Kemp SM, Chuang SH, Matsumura A, Ayuzawa S, Snead OC 3rd, Otsubo H (2009) Magnetoencephalography using total intravenous anesthesia in pediatric patients with intractable epilepsy: Lesional vs nonlesional epilepsy. Brain Dev 31(1):34–41
Funke M, Constantino T, Van Orman C, Rodin E (2009) Magnetoencephalography and magnetic source imaging in epilepsy. Clin EEG Neurosci 40(4):271–280
Goldman-Rakic PS (1998) The cortical dopamine system: role in memory and cognition. Adv Pharmacol 42:707–711
Gross J, Kujala J, Hämäläinen M, Timmermann L, Schnitzler A, Salmelin R (2001) Dynamic imaging of coherent sources: studying neural interactions in the human brain. Proc Nat Acad Sci USA 98(2):694–699
Gunduz-Bruce H (2009) The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res Rev 60(2):279–286
Halgren E (1990) Insights from evoked potentials into the neuropsychological mechanisms of reading. In: Scheibel AB, Wechsler AF (eds) Neurobiology of higher cognitive function. Guilford, New York, pp 103–150
Hall SD, Barnes GR, Furlong PL, Seri S, Hillebrand A (2010) Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco-magnetoencephalography. Hum Brain Mapp 31(4):581–594
Hall SD, Stanford IM, Yamawaki N, McAllister CJ, Ronnqvist KC, Woodhall GL, Furlong PL (2011) The role of GABAergic modulation in motor function related neuronal network activity. NeuroImage 56(3):1506–1510
Hämäläinen M, Hari R, Ilmoniemi RJ, Knuutila J, Lounasmaa OV (1993) Magnetoencephalography—theory, instrumentation, and applications to noninvasive studies of the working human brain. Rev Mod Phys 65(2):413–497
Hasselmo ME, Sarter M (2011) Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 36(1):52–73
Heal DJ, Smith SL, Findling RL (2012) ADHD: Current and future therapeutics. Curr Top Behav Neurosci 9:361–390
Hillebrand A, Barnes GR (2005) Beamformer analysis of MEG data. Int Rev Neurobiol 68:149–171
Holcomb PJ, Grainger J, O’Rourke T (2002) An electrophysiological study of the effects of orthographic neighborhood size on printed word perception. J Cogn Neurosci 14(6):938–950
Honey G, Bullmore E (2004) Human pharmacological MRI. Trends Pharmacol Sci 25(7):366–374
Honig P, Lalonde R (2010) The economics of drug development: a grim reality and a role for clinical pharmacology. Clin Pharmacol Ther 87(3):247–251
Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajos M (2008) Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discovery 7(1):68–83
Jensen O, Goel P, Kopell N, Pohja M, Hari R, Ermentrout B (2005) On the human sensorimotor-cortex beta rhythm: sources and modeling. Neuroimage 26(2):347–355
Kahkonen S (2005) MEG and TMS combined with EEG for mapping alcohol effects. Alcohol 37(3):129–133
Kahkonen S (2006) Magnetoencephalography (MEG): a non-invasive tool for studying cortical effects in psychopharmacology. Int J Neuropsychopharmacol 9(3):367–372
Kahkonen S, Ahveninen J (2002) Combination of magneto- and electroencephalography in studies of monoamine modulation on attention. Methods Find Exp Clin Pharmacol 24(Suppl C):27–34
Kenemans JL, Kahkonen S (2011) How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology 36(1):26–51
Kiebel SJ, Garrido MI, Moran R, Chen CC, Friston KJ (2009) Dynamic causal modeling for EEG and MEG. Hum Brain Mapp 30(6):1866–1876
Kirby T, Barry AE (2012) Alcohol as a gateway drug: a study of US 12th graders. J Sch Health 82(8):371–379
Klimesch W, Doppelmayr M, Stadler W, Pollhuber D, Sauseng P, Rohm D (2001) Episodic retrieval is reflected by a process specific increase in human electroencephalographic theta activity. Neurosci Lett 302(1):49–52
Klinkenberg I, Sambeth A, Blokland A (2011) Acetylcholine and attention. Behav Brain Res 221(2):430–442
Koelega HS (1995) Alcohol and vigilance performance: a review. Psychopharmacology 118(3):233–249
Konig MW, Mahmoud MA, Fujiwara H, Hemasilpin N, Lee KH, Rose DF (2009) Influence of anesthetic management on quality of magnetoencephalography scan data in pediatric patients: a case series. Paediatr Anaesth 19(5):507–512
Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217–238
Korostenskaja M, Kahkonen S (2009) What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia? Curr Pharm Des 15(22):2573–2593
Korostenskaja M, Kicic D, Kahkonen S (2008) The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study. Psychopharmacology (Berlin) 197(3):475–486
Kotini A, Anninos P, Adamopoulos A, Prassopoulos P (2005) Low-frequency MEG activity and MRI evaluation in Parkinson’s disease. Brain Topogr 18(1):59–63
Kovacevic S, Azma S, Irimia A, Sherfey J, Halgren E, Marinković K (2012) Theta oscillations are sensitive to both early and late conflict processing stages: effects of alcohol intoxication. PLoS ONE 7(8):e43957
Kuhns JB, Wilson DB, Clodfelter TA, Maguire ER, Ainsworth SA (2011) A meta-analysis of alcohol toxicology study findings among homicide victims. Addiction 106(1):62–72
Kutas M, Federmeier KD (2011) Thirty years and counting: finding meaning in the N400 component of the event-related brain potential (ERP). Annu Rev Psychol 62:621–647
Lanni C, Lenzken SC, Pascale A, Del Vecchio I, Racchi M, Pistoia F, Govoni S (2008) Cognition enhancers between treating and doping the mind. Pharmacol Res 57(3):196–213
Leiser SC, Dunlop J, Bowlby MR, Devilbiss DM (2011) Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. Biochem Pharmacol 81(12):1408–1421
Leon R, Garcia AG, Marco-Contelles J (2013) Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease. Med Res Rev 33(1):139–189
Lesko LJ, Atkinson AJ Jr (2001) Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Ann Rev Pharmacol Toxicol 41:347–366
Lesser RP (2004) MEG: good enough. Clin Neurophysiol 115(5):995–997
Leung S, Croft RJ, Baldeweg T, Nathan PJ (2007) Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology 194(4):443–451
Lin FH, Witzel T, Hämäläinen MS, Dale AM, Belliveau JW, Stufflebeam SM (2004) Spectral spatiotemporal imaging of cortical oscillations and interactions in the human brain. Neuroimage 23(2):582–595
Litvak V, Eusebio A, Jha A, Oostenveld R, Barnes G, Foltynie T, Limousin P, Zrinzo L, Hariz MI, Friston K, Brown P (2012) Movement-related changes in local and long-range synchronization in Parkinson’s disease revealed by simultaneous magnetoencephalography and intracranial recordings. J Neurosci 32(31):10541–10553
Litvak V, Jha A, Eusebio A, Oostenveld R, Foltynie T, Limousin P, Zrinzo L, Hariz MI, Friston K, Brown P (2011) Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson’s disease. Brain 134(2):359–374
Lynch G, Palmer LC, Gall CM (2011) The likelihood of cognitive enhancement. Pharmacol Biochem Behav 99(2):116–129
Lyvers M (2000) “Loss of control” in alcoholism and drug addiction: a neuroscientific interpretation. Exp Clin Psychopharmacol 8(2):225–249
Makela JP, Forss N, Jaaskelainen J, Kirveskari E, Korvenoja A, Paetau R (2006) Magnetoencephalography in neurosurgery. Neurosurgery 59(3):493–510
Marinković K, Halgren E, Maltzman I (2001) Arousal-related P3a to novel auditory stimuli is abolished by moderately low alcohol dose. Alcohol Alcohol 36(6):529–539
Marinković K, Rickenbacher E, Azma S, Artsy E (2012a) Acute alcohol intoxication impairs top-down regulation of Stroop incongruity as revealed by blood oxygen level-dependent functional magnetic resonance imaging. Hum Brain Mapp 33(2):319–333
Marinković K, Rosen BQ, Cox B, Kovacevic S (2012b) Event-related theta power during lexical-semantic retrieval and decision conflict is modulated by alcohol intoxication: Anatomically-constrained MEG. Front Psychol 3:121
Marrer E, Dieterle F (2007) Promises of biomarkers in drug development–a reality check. Chem Biol Drug Des 69(6):381–394
Mathew SJ, Shah A, Lapidus K, Clark C, Jarun N, Ostermeyer B, Murrough JW (2012) Ketamine for treatment-resistant unipolar depression: Current evidence. CNS Drugs 26(3):189–204
Mazaheri A, Jensen O (2010) Rhythmic pulsing: linking ongoing brain activity with evoked responses. Front Hum Neurosci 4:177
Moran RJ, Stephan KE, Seidenbecher T, Pape HC, Dolan RJ, Friston KJ (2009) Dynamic causal models of steady-state responses. Neuroimage 44(3):796–811
Moran RJ, Symmonds M, Stephan KE, Friston KJ, Dolan RJ (2011) An in vivo assay of synaptic function mediating human cognition. Curr Biol 21(15):1320–1325
Mucci A, Volpe U, Merlotti E, Bucci P, Galderisi S (2006) Pharmaco-EEG in psychiatry. Clin EEG Neurosci 37(2):81–98
Muller T (2012) Drug therapy in patients with Parkinson’s disease. Transl Neurodegeneration 1(1):10
Muthukumaraswamy SD, Myers JF, Wilson SJ, Nutt DJ, Lingford-Hughes A, Singh KD, Hamandi K (2012) The effects of elevated endogenous GABA levels on movement-related network oscillations. Neuroimage 66C:36–41
Naatanen R, Ilmoniemi RJ, Alho K (1994) Magnetoencephalography in studies of human cognitive brain function. Trends Neurosci 17(9):389–395
Nallasamy N, Tsao DY (2011) Functional connectivity in the brain: effects of anesthesia. Neuroscientist 17(1):94–106
Neuper C, Pfurtscheller G (2001) Event-related dynamics of cortical rhythms: frequency-specific features and functional correlates. Int J Psychophysiol 43(1):41–58
Olanow CW (2008) Levodopa/dopamine replacement strategies in Parkinson’s disease–future directions. Mov Disord 23(Suppl 3):S613–S622
Olde Dubbelink KT, Stoffers D, Deijen JB, Twisk JW, Stam CJ, Berendse HW (2013) Cognitive decline in Parkinson’s disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiol Aging 34(2):408–418
Oswal A, Brown P, Litvak V (2013) Movement related dynamics of subthalmo-cortical alpha connectivity in Parkinson’s disease. Neuroimage 70:132–142
Picciotto MR, Higley MJ, Mineur YS (2012) Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76(1):116–129
Pirmoradi M, Beland R, Nguyen DK, Bacon BA, Lassonde M (2010) Language tasks used for the presurgical assessment of epileptic patients with MEG. Epileptic Disord 12(2):97–108
Polikar R, Tilley C, Hillis B, Clark CM (2010) Multimodal EEG, MRI and PET data fusion for Alzheimer’s disease diagnosis. IEEE Eng Med Biol 2010:6058–6061
Pollok B, Makhloufi H, Butz M, Gross J, Timmermann L, Wojtecki L, Schnitzler A (2009) Levodopa affects functional brain networks in Parkinsonian resting tremor. Mov Disord 24(1):91–98
Prajapati V, Dureja H (2012) Produce lifecycle management in pharmaceuticals. J Med Mark 12(3):9
Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Nat Acad Sci USA 98(2):676–682
Rampp S, Stefan H (2007) Magnetoencephalography in presurgical epilepsy diagnosis. Expert Rev Med Devices 4(3):335–347
Rickenbacher E, Greve DN, Azma S, Pfeuffer J, Marinković K (2011) Effects of alcohol intoxication and gender on cerebral perfusion: an arterial spin labeling study. Alcohol 45(8):725–737
Ridderinkhof KR, de Vlugt Y, Bramlage A, Spaan M, Elton M, Snel J, Band GP (2002) Alcohol consumption impairs detection of performance errors in mediofrontal cortex. Science 298(5601):2209–2211
Rolinski M, Fox C, Maidment I, McShane R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. The Cochrane Database of Systematic Reviews 3:CD006504
Ross B, Tran T, Bhattacharya P, Watterson DM, Sailasuta N (2011) Application of NMR spectroscopy in medicinal chemistry and drug discovery. Curr Top Med Chem 11(1):93–114
Sahakian BJ, Morein-Zamir S (2011) Neuroethical issues in cognitive enhancement. J Psychopharmacol 25(2):197–204
Saletu B, Anderer P, Saletu-Zyhlarz GM (2006) EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. Clin EEG Neurosci 37(2):66–80
Saletu B, Anderer P, Saletu-Zyhlarz GM, Arnold O, Pascual-Marqui RD (2002a) Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA). Methods Find Exp Clin Pharmacol 24(Suppl C):97–120
Saletu B, Anderer P, Saletu-Zyhlarz GM, Pascual-Marqui RD (2002b) EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle. Methods Find Exp Clin Pharmacol 24(Suppl D):97–106
Salmelin R, Hari R (1994) Characterization of spontaneous MEG rhythms in healthy adults. Electroencephalogr Clin Neurophysiol 91(4):237–248
Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate CA Jr, Manji HK (2009) Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry 65(4):289–295
Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver F, Holroyd T, DiazGranados N, Machado-Vieira R, Grillon C, Drevets WC, Zarate CA Jr (2010) Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology 35(7):1415–1422
Sarter M, Hasselmo ME, Bruno JP, Givens B (2005) Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection. Brain Res Rev 48(1):98–111
Schomer D, Lopes da Silva FH (eds) (2010) Niedermeyer’s Electroencephalography: basic principles, clinical applications, and related fields. Lippincott Williams & Wilkins, Philadelphia
Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74(1):1–58
Seidman LJ (2006) Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev 26(4):466–485
Sivaprakasam K (2006) Towards a unifying hypothesis of Alzheimer’s disease: cholinergic system linked to plaques, tangles and neuroinflammation. Curr Med Chem 13(18):2179–2188
Stam CJ, van Cappellen van Walsum AM, Pijnenburg YA, Berendse HW, de Munck JC, Scheltens P, van Dijk BW (2002) Generalized synchronization of MEG recordings in Alzheimer’s Disease: evidence for involvement of the gamma band. J Clin Neurophysiol 19(6):562–574
Stefan H, Heers M, Schmitt HJ, Rauch C, Kaltenhauser M, Rampp S (2010) Increased spike frequency during general anesthesia with etomidate for magnetoencephalography in patients with focal epilepsies. Clin Neurophysiol 121(8):1220–1226
Stoffers D, Bosboom JL, Deijen JB, Wolters E, Stam CJ, Berendse HW (2008a) Increased cortico-cortical functional connectivity in early-stage Parkinson’s disease: An MEG study. Neuroimage 41(2):212–222
Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Berendse HW, Stam CJ (2007) Slowing of oscillatory brain activity is a stable characteristic of Parkinson’s disease without dementia. Brain 130(7):1847–1860
Stoffers D, Bosboom JL, Wolters E, Stam CJ, Berendse HW (2008b) Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson’s disease: an MEG study. Exp Neurol 213(1):191–195
Stufflebeam SM (2011) Clinical magnetoencephalography for neurosurgery. Neurosurg Clin N Am 22(2):153–167
Szmuk P, Kee S, Pivalizza EG, Warters RD, Abramson DC, Ezri T (2003) Anaesthesia for magnetoencephalography in children with intractable seizures. Paediatr Anaesth 13(9):811–817
Tracey I (2001) Prospects for human pharmacological functional magnetic resonance imaging (phMRI). J Clin Pharmacol 41:21S–28S
Trimble MR, Hindmarch I (eds) (2000) Benzodiazepines. Wrightson Biomedical Publishing, Petersfield
Uhlhaas PJ, Pipa G, Lima B, Melloni L, Neuenschwander S, Nikolic D, Singer W (2009) Neural synchrony in cortical networks: History, concept and current status. Front Integr Neurosci 3:17
Uutela K, Hämäläinen M, Somersalo E (1999) Visualization of magnetoencephalographic data using minimum current estimates. Neuroimage 10(2):173–180
Van Veen BD, van Drongelen W, Yuchtman M, Suzuki A (1997) Localization of brain electrical activity via linearly constrained minimum variance spatial filtering. IEEE Trans Bio-Medical Eng 44(9):867–880
Vardy AN, van Wegen EE, Kwakkel G, Berendse HW, Beek PJ, Daffertshofer A (2011) Slowing of M1 activity in Parkinson’s disease during rest and movement–an MEG study. Clin Neurophysiol 122(4):789–795
Varela F, Lachaux JP, Rodriguez E, Martinerie J (2001) The brainweb: phase synchronization and large-scale integration. Nat Rev Neurosci 2(4):229–239
WHO (2006) Neurological disorders: public health challenges. World Health Organization, Geneva
WHO (2008) The global burden of disease: 2004 update. World Health Organization, Geneva
Wienbruch C, Paul I, Bauer S, Kivelitz H (2005) The influence of methylphenidate on the power spectrum of ADHD children—an MEG study. BMC Psychiatry 5:29
Wilens TE (2006) Mechanism of action of agents used in attention-deficit/hyperactivity disorder. J Clin Psychiatry 67(Suppl 8):32–38
Wilens TE, Morrison NR, Prince J (2011) An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother 11(10):1443–1465
Willcutt EG (2012) The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9(3):490–499
Wilson TW, Franzen JD, Heinrichs-Graham E, White ML, Knott NL, Wetzel MW (2013) Broadband neurophysiological abnormalities in the medial prefrontal region of the default-mode network in adults with ADHD. Hum Brain Mapp 34(3):566–574
Wilson TW, Wetzel MW, White ML, Knott NL (2012) Gamma-frequency neuronal activity is diminished in adults with attention-deficit/hyperactivity disorder: a pharmaco-MEG study. J Psychopharmacol 26(6):771–777
Wise RG, Tracey I (2006) The role of fMRI in drug discovery. J Magn Reson Imaging 23(6):862–876
Wong DF, Tauscher J, Grunder G (2009) The role of imaging in proof of concept for CNS drug discovery and development. Neuropsychopharmacology 34(1):187–203
Acknowledgments
I am grateful to the National Institutes of Health (R01AA016624) for their continued support and to Burke Rosen and Sanja Kovacevic for their kind assistance.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Marinković, K. (2014). Neuropsychopharmacology: Recent MEG Investigations. In: Supek, S., Aine, C. (eds) Magnetoencephalography. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-33045-2_42
Download citation
DOI: https://doi.org/10.1007/978-3-642-33045-2_42
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-33044-5
Online ISBN: 978-3-642-33045-2
eBook Packages: EngineeringEngineering (R0)